Life Sciences in India-Finance
5 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by TwoFour Insight Group
Scoop.it!

Explicit cookie consent

The Economist offers authoritative insight and opinion on international news, politics, business, finance, science, technology and the connections between them.
more...
No comment yet.
Scooped by TwoFour Insight Group
Scoop.it!

Daiichi Sankyo introduces nine new generic drugs

Daiichi Sankyo introduces nine new generic drugs | Life Sciences in India-Finance | Scoop.it
Daiichi Sankyo introduces nine new generic drugs
more...
No comment yet.
Scooped by TwoFour Insight Group
Scoop.it!

Government might cap maximum retail price of critical medical devices like stents - The Economic Times on Mobile

Government might cap maximum retail price of critical medical devices like stents - The Economic Times on Mobile | Life Sciences in India-Finance | Scoop.it
The regulator is of the view that because of over dependency on imported medical devices, prices of these products have gone up stupendously in past few years.
more...
No comment yet.
Scooped by TwoFour Insight Group
Scoop.it!

Medybiz study indicates 30% spike derma medication consumption, 40% rise in vaccine use

Medybiz study indicates 30% spike derma medication consumption, 40% rise in vaccine use | Life Sciences in India-Finance | Scoop.it
Medybiz study indicates 30% spike derma medication consumption, 40% rise in vaccine use
more...
No comment yet.
Scooped by TwoFour Insight Group
Scoop.it!

Govt for reducing imports of pharma raw materials

India decides to frame policy that will incentivize local manufacturing of raw materials, bulk drugs
TwoFour Insight Group's insight:
After allowing China to lead API sector in order to move up to FDFs, India looking to move back into the API and raw materials space.
more...
No comment yet.
Scooped by TwoFour Insight Group
Scoop.it!

Business Standard

Business Standard | Life Sciences in India-Finance | Scoop.it
Business Standard, India's leading destination for latest news, analysis and opinion on markets, companies, industry, economy, policy, banking and personal finance.
more...
No comment yet.
Scooped by TwoFour Insight Group
Scoop.it!

Ministry of MSME identifies medical device sector for Japanese investment

Ministry of MSME identifies medical device sector for Japanese investment | Life Sciences in India-Finance | Scoop.it
Ministry of MSME identifies medical device sector for Japanese investment
more...
No comment yet.
Scooped by TwoFour Insight Group
Scoop.it!

After price control, several key drugs in short supply - The Economic Times on Mobile

After price control, several key drugs in short supply - The Economic Times on Mobile | Life Sciences in India-Finance | Scoop.it
Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a thyroid medicine) among others.
more...
No comment yet.
Scooped by TwoFour Insight Group
Scoop.it!

ComMin floats draft note on relaxing FDI in medical devices

The Commerce and Industry Ministry has circulated a draft Cabinet note for inter-ministerial comments on liberalising foreign direct investment (FDI) policy in medical devices.
more...
No comment yet.